--2025/Q1-- / 12.977B--
--2024/Q4-- / 13.981B--
Oct 30, 20242024/Q311.439B / 12.119B--
Apr 30, 20242024/Q18.768B / 8.930B--
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 767.760
- +10.220+1.35%
Close Dec 20 16:00 ET
- 780.990
- +13.230+1.72%
Post 20:01 ET
728.85BMarket Cap83.00P/E (TTM)
811.350High766.610Low9.94MVolume811.350Open757.540Pre Close7.81BTurnover1.05%Turnover Ratio132.37P/E (Static)949.32MShares970.91652wk High51.18P/B727.28BFloat Cap563.94552wk Low5.03Dividend TTM947.28MShs Float970.916Historical High0.66%Div YieldTTM5.91%Amplitude5.278Historical Low785.311Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q3 2024 Earnings Date
Overview | Lilly reported revenue of $11.4 billion, a 20% year-over-year increase, along with earnings per share (EPS) of $1.18, which fell short of Wall Street estimates
Currency：USDOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 12.12B | 11.44B | -679.50M |
| Miss Est. | +27.58% | +20.43% | -5.61% |
| EPS | 1.54 | 1.07 | -0.47 |
| Miss Est. | +2677.80% | +1883.33% | -30.70% |
Analyst Rating
Dec 20, 2024
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
